Amarin hit hard as generics loom for fish oil drug VascepaGeneric drugmakers Hikma and Dr Reddy’s Laboratories have won a surprise victory in a US patent lawsuit that Share XAmarin hit hard as generics loom for fish oil drug Vascepahttps://pharmaphorum.com/news/amarin-hit-hard-as-generics-loom-for-fish-oil-drug-vascepa/
Amarin gets FDA panel okay for new Vascepa indicationAmarin is on course to significantly increase the number of patients eligible for treatment with its purified fish Share XAmarin gets FDA panel okay for new Vascepa indicationhttps://pharmaphorum.com/news/amarin-gets-fda-panel-okay-for-new-vascepa-indication/
Amarin’s Vascepa gets priority review for cardiovascular label expansionAmarin’s cardio drug Vascepa (icosapent ethyl) has been granted Priority Review designation by the FDA after trial results Share XAmarin’s Vascepa gets priority review for cardiovascular label expansionhttps://pharmaphorum.com/news/amarins-vascepa-gets-priority-review-for-cardiovascular-label-expansion/
